perflenapent Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
perfluorinated compounds used as blood substitutes and/or diagnostic agents 4685 678-26-2

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • perflenapent
  • perfluoropentane
a phase shift contrast agent that uses dodecafluoropentane as the enhancing gas
  • Molecular weight: 288.04
  • Formula: C5F12
  • CLOGP: 3.45
  • LIPINSKI: 0
  • HAC: 0
  • HDO: 0
  • TPSA:
  • ALOGS: -3.88
  • ROTB: 4

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

Pharmacologic Action:

SourceCodeDescription
ATC V08DA03 VARIOUS
CONTRAST MEDIA
ULTRASOUND CONTRAST MEDIA
Ultrasound contrast media
MeSH PA D003287 Contrast Media
MeSH PA D064907 Diagnostic Uses of Chemicals
CHEBI has role CHEBI:37338 radioopaque media

Drug Use (View source of the data)

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D05436 KEGG_DRUG
CHEBI:39428 CHEBI
CHEMBL1899801 ChEMBL_ID
C008806 MESH_SUPPLEMENTAL_RECORD_UI
7528 INN_ID
DB11625 DRUGBANK_ID
483AU1Y5CZ UNII
12675 PUBCHEM_CID
2474632 RXNORM
418025004 SNOMEDCT_US
418852008 SNOMEDCT_US
C0666513 UMLSCUI

Pharmaceutical products:

None